Cardiovascular Monitoring and Diagnostic Devices Market - current status and future directions.

Intense competition and high entry barriers outline the present state of the competitive landscape of the global cardiovascular monitoring and diagnostic devices market, states a recent Transparency Market Research (TMR) report. In the markedly consolidated market, the top two vendors, GE Healthcare and Philips Healthcare, accounted for a more than 55% share in 2015. Moreover, these two companies have their headquarters in Europe, granting this regional market a high level of saturation. The other half of the competitive landscape is, however, highly fragmented with a large number of specialty vendors operating in regional pockets.

However, the rising prevalence of a number of cardiovascular diseases coupled with the rising global demand for technologically advanced and innovative devices would attract new entrants to the market. As a result, the competition in the market is expected to further intensify in the next few years. Pulling ahead in these foreseeable tough times will require alignment of business strategies towards untapped opportunities in several regional territories and innovative ways of promoting products. Other key vendors operating in the global cardiovascular monitoring and diagnostic devices market include Spacelabs Healthcare, St. Jude Medical, Inc., and Siemens Healthcare.

Read Full Report: http://www.transparencymarketresearch.com/crdiovascular-monitoring-diagnostic-devices.html

Vast Geriatric Population Base and Flourishing Medical Tourism Industry Key to Market’s Growth

According to estimates derived by the United Nations University (UNU), the share of people aged above 65 years in the global population is expected to rise from 7% in 2000 to 16% by 2050. As people above the age of 65 years are more prone to acquiring cardiovascular diseases, the vast rise in the world’s geriatric population in the near future will stimulated demand for effective cardiovascular monitoring and diagnostic devices.

Additionally, the flourishing sector of medical tourism in developing countries will have a sizeable impact on the consumption of a variety of cardiovascular monitoring and diagnostic devices in regions such as Asia Pacific and Middle East in the next few years. Low procedural costs and availability of reliable and affordable labor in countries such as Turkey, India, China, and Indonesia will make them the most preferred foreign destinations for undertaking complex cardiovascular diagnosis and surgeries.

Factors such as inadequate physical activities, unhealthy diets, high stress levels, and rising consumption of tobacco and alcohol are substantially increasing risk of cardiovascular disorders in the global population. This has also emerged as a high-impact driver of the global cardiovascular monitoring and diagnostic devices market in the past few years.

View exclusive Global strategic Business Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2385

Lack of Favorable Reimbursement Policies and High Cost of Advanced Devices Challenge Expansion across Developing Economies

For most varieties of cardiovascular monitoring and diagnostic devices available in the market presently, high costs and limited or inadequate reimbursement policies are the key hindrances that limit the overall development of the market to a certain extent. In developed regions such as the U.S., Japan, and many European countries, the high costs of devices are supported by sufficient reimbursement for purchasing these devices and tests. However, post purchase activity costs, involving costs for recording and testing activities are not covered under reimbursement policies, bringing down the attractiveness of high-end cardiovascular monitoring and diagnostic devices, especially across cost-sensitive developing regions.

The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder is expected to expand at the highest CAGR of 7.1% over the period between 2016 and 2024. Geography-wise, Asia Pacific will present the most promising growth opportunities over the said period, expanding at a 7.1% CAGR.

This review of the global cardiovascular monitoring and diagnostic devices market is based on a recent market research report published by Transparency Market Research, titled “Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Urolithiasis Management Devices Market expected to rise to US$1.78 bn up to 2024

The global demand for urolithiasis management devices has seen a steady rise in the past few years owing to the increasing prevalence of kidney stones. A 2015 study by the National Kidney Foundation of the U.S. states that one in 10 people in the country has kidney stones and that more than a half a million people are admitted to emergency rooms for kidney stone management every year. Across the globe as well, factors such as obesity, rising geriatric population, which is highly susceptible to kidney stones owing to reduced renal function and diabetes, and change in lifestyles are contributing to increased prevalence of kidney stone formation.

Transparency Market Research estimates that the global urolithiasis management devices market will exhibit a healthy 4.5% CAGR over the period between 2016 and 2024 and rise to a valuation of US$1.78 bn by 2024.

Read Full Report: http://www.transparencymarketresearch.com/urolithiasis-management-devices-market.html

Clinics and Ambulatory Surgical Centers to Remain Dominant End-use Segments

Of the key end-users of urolithiasis management devices, including hospitals, ambulatory surgery centers (ASCs), and clinics, the segment of clinics led the global market in terms of both revenue and volume in 2015. In terms of revenue, the segment accounted for over 55% in the said year. The leading position of the market segment can be attributed to factors such as the significant rise in the number of people opting for urolithiasis surgeries and advancements in treatment options that have reduced the time required for undertaking the procedures. Over the period between 2016 and 2024 as well, the segment is expected to hold a commanding position in the global market, retaining its status as the leading revenue generator.

The demand for urolithiasis management devices across ambulatory surgical centers is expected to exhibit a strong growth over the next few years, with the end-user segment emerging as one of the most promising investment grounds for the global urolithiasis management devices market. The segment is expected to exhibit strong growth owing to high demand for ambulatory surgical centers and preference for day care surgeries across developing as well as developed parts of the world. Applications of urolithiasis management devices across the hospitals end-use segment is expected to witness stagnant growth as clinics and ambulatory surgical settings become more preferred owing to the lower cost of treatment and the need to be hospitalized for shorter lengths of time.

Rising Geriatric Population in Asia Pacific to Stimulate Increased Adoption

North America held a dominant share of nearly 36% in the global urolithiasis management devices market in 2015. Factors such as the rising prevalence of kidney stone, rising geriatric population, and campaigns undertaken to raise awareness about the risks associated with kidney stones by government bodies are central to the growth of the market in the region. Additionally, the introduction of new and innovative urolithiasis management devices such as laser lithotripters and flexible ureterenoscopes have also aided the healthy growth of the North America urolithiasis management devices market. The presence of high disposable income groups across developed economies such as the U.S. and Canada in North America, with a high prevalence of lifestyle-induced diseases such as obesity and a large base of geriatric population have also influenced the increased adoption of urolithiasis management devices.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2252

The urolithiasis management devices market in Asia Pacific is expected to exhibit an impressive CAGR of 4.6% over the period between 2016 and 2024. The mounting geriatric population in the region is the key factor driving the urolithiasis management devices market in the next few years. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific), is region is presently home to more than half of the world’s population of people aged over 60 years and the number is expected to rise to more than 2.45 bn by 2050. Owing to this, the regions is expected to lead to a substantial rise in demand for urolithiasis management devices in the next few years.

Some of the key vendors operating in the global urolithiasis management devices market are C. R. Bard, Inc., Allengers Medical Systems Ltd, Dornier Medtech GmbH, Boston Scientific Corporation, Cook Group, Inc., Electro Medical Systems S.A., DirexGroup, Olympus Corporation, Karl Storz, and Siemens Healthcare.

Global Telemedicine Market to Reach US$36.30 bn by 2020; Growth Spurred by High Personal Healthcare Demand

The valuation of the global telemedicine market was recorded at US$14.30 bn in 2014. After a forecasted progression at a CAGR of 14.30% between 2014 and 2020, this market is expected to reach US$36.30 bn in 2020, according to a market intelligence study published by Transparency Market Research. The report, titled “Telemedicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” highlights the key trends, opportunities, and challenges of this market in the given forecast period, thus providing users with valuable knowledge for the purpose of strengthening their position in this market.

According to the report, the largest driver for the growth of the global telemedicine market is the increasing demand for better personal healthcare methods. A larger percentage of the population is able to express their need for faster and sharper diagnostics and medical attention thanks to their increased spending ability; integrating modern telecommunications with healthcare is one of the best ways to achieve that.

Other drivers of the global telemedicine market are the increasing need for data privacy, larger number of supportive reimbursement policies, and positive government initiatives and investments. Additionally, the growth of the global telemedicine market will also lead towards meeting one of the healthcare industry’s largest targets: the rural population. People living in rural areas, or even those that live in remote and difficult-to-access regions can easily be helped through the use of telecom services in medicine.

The report also warns its users of the various restraints associated with the global telemedicine market, the most prominent of which is the current lack of skilled labor required for operating the devices in this market. The lack of standard or professional training for the use of telemedicine is causing healthcare organizations to achieve unfavorable response times. Another issue persistent in the global telemedicine market is the lack of confidence that telemedicine can impart to patients, regarding the accuracy of medical assessment.

The report provides details on the global telemedicine market in a segmented fashion. The market is segmented by specialty, service type, and geography.

In terms of specialty, the global telemedicine market is segmented into gynecology, emergency care, internal medicine, orthopedics, neurology, cardiology, dermatology, and others. The market will benefit from the neurology segment, which is progressing at the fastest CAGR of 15.90% in the market, within the given forecast period.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032

In terms of service types, the global telemedicine market is segmented into tele-surgery, tele-care, tele-education, tele-consultation, and tele-monitoring. Tele-consultation led the global telemedicine market in the 2013, while tele-monitoring is expected to be the fastest-growing segment till 2020. This is attributed to the growing geriatric demographic that is in greater need of home healthcare.

The geographical segmentation of the global telemedicine market reveals North America to be the largest region in terms of revenue, in 2013. Meanwhile, the fastest growth rate in the market, over the given forecast period, is attributed to Asia Pacific owing to a high population density and a rapidly developing healthcare infrastructure.

The key players in the global telemedicine market are McKesson Corp., Siemens Healthcare, Medtronic, Inc., Allscripts Healthcare Solutions, LifeWatch AG, Medtronic, Inc., Agfa HealthCare NV, OBS Medical Ltd., Honeywell HomMed LLC, and AMD Global Telemedicine, Inc.

Mounting Population of Geriatric and Obese People Globally to be Key Drivers of Urolithiasis Management Devices Market, report TMR

The global demand for urolithiasis management devices has seen a steady rise in the past few years owing to the increasing prevalence of kidney stones. A 2015 study by the National Kidney Foundation of the U.S. states that one in 10 people in the country has kidney stones and that more than a half a million people are admitted to emergency rooms for kidney stone management every year. Across the globe as well, factors such as obesity, rising geriatric population, which is highly susceptible to kidney stones owing to reduced renal function and diabetes, and change in lifestyles are contributing to increased prevalence of kidney stone formation.

Transparency Market Research estimates that the global urolithiasis management devices market will exhibit a healthy 4.5% CAGR over the period between 2016 and 2024 and rise to a valuation of US$1.78 bn by 2024.

Clinics and Ambulatory Surgical Centers to Remain Dominant End-use Segments

Of the key end-users of urolithiasis management devices, including hospitals, ambulatory surgery centers (ASCs), and clinics, the segment of clinics led the global market in terms of both revenue and volume in 2015. In terms of revenue, the segment accounted for over 55% in the said year. The leading position of the market segment can be attributed to factors such as the significant rise in the number of people opting for urolithiasis surgeries and advancements in treatment options that have reduced the time required for undertaking the procedures. Over the period between 2016 and 2024 as well, the segment is expected to hold a commanding position in the global market, retaining its status as the leading revenue generator.

The demand for urolithiasis management devices across ambulatory surgical centers is expected to exhibit a strong growth over the next few years, with the end-user segment emerging as one of the most promising investment grounds for the global urolithiasis management devices market. The segment is expected to exhibit strong growth owing to high demand for ambulatory surgical centers and preference for day care surgeries across developing as well as developed parts of the world. Applications of urolithiasis management devices across the hospitals end-use segment is expected to witness stagnant growth as clinics and ambulatory surgical settings become more preferred owing to the lower cost of treatment and the need to be hospitalized for shorter lengths of time.

Rising Geriatric Population in Asia Pacific to Stimulate Increased Adoption

North America held a dominant share of nearly 36% in the global urolithiasis management devices market in 2015. Factors such as the rising prevalence of kidney stone, rising geriatric population, and campaigns undertaken to raise awareness about the risks associated with kidney stones by government bodies are central to the growth of the market in the region. Additionally, the introduction of new and innovative urolithiasis management devices such as laser lithotripters and flexible ureterenoscopes have also aided the healthy growth of the North America urolithiasis management devices market. The presence of high disposable income groups across developed economies such as the U.S. and Canada in North America, with a high prevalence of lifestyle-induced diseases such as obesity and a large base of geriatric population have also influenced the increased adoption of urolithiasis management devices.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2252

The urolithiasis management devices market in Asia Pacific is expected to exhibit an impressive CAGR of 4.6% over the period between 2016 and 2024. The mounting geriatric population in the region is the key factor driving the urolithiasis management devices market in the next few years. According to the United Nations ESCAP (Economic and Social Commission for Asia and the Pacific), is region is presently home to more than half of the world’s population of people aged over 60 years and the number is expected to rise to more than 2.45 bn by 2050. Owing to this, the regions is expected to lead to a substantial rise in demand for urolithiasis management devices in the next few years.

Some of the key vendors operating in the global urolithiasis management devices market are C. R. Bard, Inc., Allengers Medical Systems Ltd, Dornier Medtech GmbH, Boston Scientific Corporation, Cook Group, Inc., Electro Medical Systems S.A., DirexGroup, Olympus Corporation, Karl Storz, and Siemens Healthcare.

Cardiovascular Monitoring and Diagnostic Devices Market - current status and future directions.

Being the leading cause of death and witnessing a high rise in prevalence, the class of ailments that come under the purview of cardiovascular diseases is witnessing increased focus from healthcare, research, and government bodies alike. A large number of companies are venturing into the market with an innovative range of products for diagnosing and treating a variety of cardiovascular diseases. Research and development activities are being granted increasingly more funds and governments bodies are implementing various health schemes aimed at reducing the prevalence and improving awareness about cardiovascular diseases.

Transparency Market Research states that the global cardiovascular monitoring and diagnostic devices market held an opportunity of US$1.8 bn in 2015. The market is expected to expand at a 6.4% CAGR over the period between 2016 and 2024, and rise to a valuation of US$3.1 bn by 2024.

Electrocardiogram (ECG) Systems Lead on Account of Cost Effectiveness and High Efficiency

The product segment of ECG systems presently holds the largest share in the global cardiovascular monitoring and diagnostic devices market. The widespread presence and high preference for ECG systems in developed and developing regions alike are key to the segment’s leading market position. ECG systems are expected to remain the key contributor to the market’s overall revenues over 206 and 2024 as well, expanding at a 6.3% CAGR in the global market.

However, the segment of implantable loop recorders is expected to witness the fastest expansion, a 7.1% CAGR from 2016 to 2024. The segment is projected to benefit from the rising awareness about the use of these devices in diagnosing syncope. As several cases of the disease remain undiagnosed when other conventional diagnostic methods are used, implantable loop recorders are gaining an increased level of adoption across medical diagnostic centers globally. The valuation of the segment is expected to reach US$152.7 mn by 2024.

The segment of Holter monitors also holds immense growth promise owing to the rising prevalence of conditions such as arrhythmia and conduction block. The segment was valued at US$416.1 mn in 2015 and is expected to expand at a high single-digit CAGR from 2016 to 2024.

North America to Continue Taking Largest Share of Pie but Emerging Economies Hold More Promise

North America accounted for the largest share of the overall revenues of the global cardiovascular monitoring and diagnostic devices market in 2015. The region is expected to remain the largest market over the period between 2016 and 2024 as well. Factors such as favorable reimbursement policies, high awareness about available diagnosis and treatment methods among patients and physicians, favorable reimbursement policies, and efficient healthcare infrastructure are factors that will help North America remain at the forefront of the global market. Europe, the second largest contributor to the global cardiovascular monitoring and diagnostic devices market in 2015, will also remain a lucrative owing to large scale healthcare infrastructure development activities and rising prevalence of cardiovascular disease.

View exclusive Global strategic Business Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2385

However, developing regions such as Latin America and Asia Pacific will present the most promising growth opportunities for the global cardiovascular monitoring and diagnostic devices market over the period between 2016 and 2024. The presence of vast untapped growth prospects, rising healthcare expenditure, and increasing awareness about the efficiency of available techniques and devices in effectively curing several cardiovascular conditions will remain key to the overall growth of the market.

Several research studies also state that the risk of cardiovascular diseases is substantially high in mid- and low-income economies. This substantiates the fact that a large variety of cardiovascular monitoring and diagnostic devices will be consumed in Asia Pacific and Latin America in the next few years. The market for these devices will expand at a 7.5% in Asia Pacific and a 7.3% CAGR in Latin America over the period between 2016 and 2024.

In the highly dynamic global market for cardiovascular monitoring and diagnostic devices market, the top two vendors, GE Healthcare and Philips Healthcare accounted for a more than 55% of the global market in 2015. Other key vendors in the market are Spacelabs Healthcare, St. Jude Medical, Inc., and Siemens Healthcare.

Contact Lens Market Driven Advancement in Medical Sciences to deal with Ophthalmological Diseases

The global market for contact lenses features a consolidated competitive landscape, with the top four companies, including Johnson & Johnson, The Cooper Companies, Alcona Inc. and Bausch and Lomb, accounting for a share of nearly 68% in the global market in 2015, states Transparency Market Research (TMR) in a new report. Johnson & Johnson, the largest vendor in the market, held nearly 31% share in the global market in the same year.

Volume-wise, the Contact Lens market is expected to rise to 2,135.0 mn units by 2024. TMR also estimates that the global contact lens market, which had a valuation of US$9.74 bn in 2015 in terms of revenue, is expected to expand at a 7.6% CAGR from 2016 through 2024, and rise to US$18.70 bn by 2024. Of the key technologies used for manufacturing contact lenses, the cast molding technology is presently the most preferred, accounting for a share of over 80% of the market’s overall revenues in 2015.

Rising Prevalence of Ophthalmic Disorders and Rising Popularity as Fashion Accessory Boost Global Sales of Contact Lenses

The vast rise in the world’s population that suffers from a variety of ophthalmic disorders has emerged as the primary growth driver of the global contact lens market lately. The rise in younger population with issues such as refractory errors and weakened eyesight have especially increased the global consumption of contact lenses, which are being increasingly preferred for their comfort, convenience, and aesthetics.

The easy availability of colored, disposable, and affordable varieties of contact lenses have also led to the vast rise in their usage as fashion accessories globally. Attempts made by contact lens manufacturers to educate masses about the proper and safe use of contact lenses and the availability of vast product varieties across distant corners of the globe have also helped stimulate the growth of the global contact lens market in the past few years.

Concerns Regarding Damage from Careless Usage Continue to Limit Large-scale Adoption

Owing to the fact that contact lenses are worn directly on the cornea of the eye, they are required to be handled with exceptional care to prevent eye infections, ulcerations and other eye diseases. It is thus a widely known fact that careless handling or storage of contact lenses, or sleeping with the lenses on can have severe implications after the lenses are worn and remains a key challenge hindering the large-scale usage of contact lenses among skeptical consumers.

Along with this, the fact that practitioners are not well equipped to prescribe contact lenses in certain developing economies across regions such as Asia Pacific and Middle East also threatens to limit the overall growth prospects of the global contact lens market to a certain extent.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1787

Emerging Economies to Present Excellent Growth Opportunities

Nevertheless, the vast untapped opportunities in developing regions can allow vendors in the market to gain substantial traction in the next few years. Expansion across these regions will require innovative marketing strategies and ways of educating the masses about the proper usage of contact lenses will have to be adopted. Over the period between 2016 and 2024, the market for contact lenses in Asia Pacific is expected to expand at a considerable CAGR. The APAC market is expected to reach US$4.76 bn by 2024.

Prominent vendors in the market, including Novartis International AG, Menicon Group, STAAR Surgical, Carl Zeiss AG, SynergEyes Inc., Abbott Medical Optics, Inc., Essilor International S.A., Valeant Pharmaceuticals, and Bausch and Lomb have strengthened their hold in regional markets with these approaches. Strategies such as innovation and new product development, high investments in research and development, and exploitation of novel marketing and sales channels have also helped key companies hold sway in the market in the past years. Incorporation of new technologies for upgradation of products and strategic acquisitions entered-in with the aim of expanding product portfolios and market position across regional markets will help companies in beating competition in the next few years.

This review of the global contact lens market is based on a recent market research report published by Transparency Market Research, titled “Contact Lens Market -Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024.”

Global Preventive Healthcare Technologies and Services Market to Register CAGR of 9.70% 2014-2020, Propelled by Rising Demand to Curb Costs

The competitive landscape of the global preventive healthcare technologies and services market includes players such as Dilon Technologies Inc., Alere Inc., Medtronic Inc., Healthways Inc., Omron Healthcare Inc., Merck & Co. Inc., and ScriptPro LLC. The key players are investing heavily in proteomics and genomics with the increased demand for personalized medicines. Furthermore, the market players are focusing on emerging economies where the market has a significant potential to grow in the near future.

High Cost of Installation to Restrain Growth of Global Preventive Healthcare Technologies and Services Market

Increasing public awareness about prophylaxis and constructive government policies have played a pivotal role in the growth of the global preventive healthcare technologies and services market. The introduction of advanced technologies has significantly reduced the cost of healthcare. However, high costs of installation and maintenance of healthcare IT solutions have dampened the adoption of preventive healthcare technologies and services. “Deficient patient engagement activities have hampered the motivation of physicians and pharmacists to adopt preventive healthcare technologies,” a TMR analyst notes.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=822

Favorable Regulatory Environment Augments Demand for Preventive Healthcare Technologies and Services across North America

North America remains the largest market for preventive healthcare technologies and services and is anticipated to retain its position during the forecast horizon. A conductive regulatory environment and a comprehensive healthcare reimbursement scenario have helped the growth of the market across this region. In 2003, the United States Medicare Prescription Drug Improvement and Modernization Act made provisions for physicians to avail grants worth US$50 mn to cover the costs of acquisition, installation, and upgrade of preventive healthcare software solutions and technologies. The act also made provisions for availing funds for training staffs. This significantly encouraged the regional healthcare facilities to adopt IT services, thereby aiding the growth of the global healthcare technologies and services market.

Lack of Robust Healthcare Structure Hampers Growth of Global Preventive Healthcare Technologies and Services Market across Asia Pacific

Europe is the second largest market for preventive healthcare technologies and services. Though the market has ample opportunities to grow across Asia Pacific and Rest of the World, the rate of adoption of preventive healthcare services in these regions is expected to be slow. “The sluggishness in the growth of these regional markets can be attributed to the lack of a robust healthcare infrastructure,” TMR report states.

The global preventive healthcare technologies and services market is anticipated to expand at a CAGR of 9.7% during the period from 2014 to 2020. The overall market was worth US$72.8 bn in 2013 and is projected to reach a valuation of US$144.8 bn by 2020.

The review is based on the findings presented by a report published by Transparency Market Research, titled “Preventive Healthcare Technologies and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014-2020.”

Total Ankle Replacement Market - Trends and Forecast, 2013 – 2019

Total ankle replacement is a surgical process for replacing damaged bones in the ankle joint. Total ankle replacement is performed by placing a plastic or metal implant on top of the ankle bone (talus) and at the end of the shin bone (tibia). Loss of movement and pain in the ankle are the common symptoms. Bone fracture, arthritis, osteoarthritis, and rheumatoid arthritis are some of the primary reasons for total ankle replacement. Arthrodesis and total ankle replacement are the two common types of total ankle replacement surgeries. Recovery period for the total ankle replacement surgery is up to three months after the surgery. Some of the risks associated with ankle replacement are ankle weakness, bone damage during surgery, stiffness, nerve damage, allergic reactions to the artificial joint, and blood vessel damage. Growing awareness about these risks associated with the total ankle replacement surgeries are expected to hamper the growth of the global total ankle replacement market.

The global total ankle replacement market is segmented on the basis of design and geography. By geography, the global total ankle replacement market was dominated by North America in 2013 in terms of revenue and the region is expected to maintain its dominant position throughout the forecast period.

The overview section of the report provides comprehensive data on market drivers, factors limiting the growth of the market, current market trends, market structure, and predictions for the years to come. The report on the global total ankle replacement market is a complete study of changing trends, restraints, and industry growth drivers. The report presents a blueprint that highlights analysis of technology developments. A detailed review of macro and micro factors that are affecting the growth of the market are highlighted in the report. The Porter’s five forces model is used to measure the feasibility of new projects and competitive analysis.

Overview of the Total Ankle Replacement Market

By design, the global total ankle replacement market is classified into agility ankle prosthesis, Buechel-Pappas ankle prosthesis, Scandinavian total ankle replacement (STAR), Salto total ankle replacement, HINTEGRA total ankle replacement, mobility ankle system, TNK total ankle replacement, Ramses total ankle replacement, AES total ankle replacement, BOX total ankle replacement, ESKA ankle prosthesis, German ankle system, alphanorm total ankle replacement, TARIC total ankle replacement, and INBONE total ankle replacement. Based on geography, the global total ankle replacement market is divided into North America, Europe, Asia Pacific, and Rest of the World. The Europe total ankle replacement market is expected to rise due to rising awareness amongst people and the increasing obese population. Asia Pacific is predicted to be the emerging region in the global total ankle replacement market during the forecast period due to increasing awareness about advanced medical technology.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2182

Risks such as continued pain, mal-alignment, and arthritis development in the adjacent joints are expected to restrict the growth of the global total ankle replacement market in the years to come. However, the growing aging population is a key factor expected to drive the global total ankle replacement market during the period from 2013 to 2019.

Companies mentioned in the research report

Integra Life Sciences, Implants International, Small Bone Innovation, Inc., DePuy Synthes, Zimmer Holdings, Inc., and KYOCERA Medical Corporation are some of the leading companies operating in the global total ankle replacement market. The leading companies are expected to face competition from the emerging companies in the years to come.

Intravascular Ultrasound Devices Market Set to Expand by 2019

Intravascular ultrasound (IVUS) is a medical imaging methodology using a specially designed catheter with miniaturized ultrasound probe attached to the distal end. The proximal end of the catheter is attached to computerized ultrasound equipment. It allows application of ultrasonic technology to visualize the blood vessels internally through surrounding blood column. The arteries of the heart (the coronary arteries) are the most frequent imaging target for IVUS. The application of IVUS in coronary arteries is to determine the amount of atheromatous plaque built up at any particular point in epicardial coronary artery. Built up plaque obstructs the blood flow, disturbs the normal blood pressure in body and raises coronary heart complications (e.g. Stenosis). IVUS is a valuable adjunct to angiography, providing new insights in the diagnosis and therapy for coronary diseases. An angiography depicts only 2D silhouette of the lumen, whereas IVUS allows tomographic assessment of lumen area, plaque size, distribution, and composition. According to experts the range of lumen stenosis locations at which myocardial infarctions occur range from areas of acute dilatation all the way to areas of greater than 95% stenosis. However, the average or typical stenoses at which myocardial infarctions occur were found to be less than 50%. Only 14% of the heart attacks occurred at locations with 75% or more due to stenosis. Overall this research has changed the primary focus of heart attack from severe narrowing to vulnerable plaque. According to WHO, it has been estimated that around 17.3 million people died from CVDs in 2008, representing 30% of all the global deaths. Of these deaths, an estimated 7.3 million were due to coronary heart disease and 6.2 million were due to stroke.

The IVUS market can be segmented on the basis of products and applications:

Products

• IVUS Consoles
• IVUS Catheters

IVUS Accessories market ( pullback devices, guidewires, others)

Applications

• IVUS coronary diagnostic market
• IVUS coronary intervention market
• IVUS coronary research market
• IVUS non-coronary /peripheral applications market

Some of the major market drivers of Intravascular Ultrasound Devices market are sedentary lifestyle, increasing incidence and prevalence of cardiovascular diseases rising obese population and aging population. Some of the major restraining factors of this market are high cost of diagnostic devices and lack of uniform reimbursement policies. Most of the market experts expect that future research and developments activities in the field will enhance the application range and efficiency of IVUS as it’s currently at initial stage.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2208

Asia-Pacific market was observed to be the leading IVUS market as Japan represents the largest regional market for intravascular ultrasound worldwide. This was observed due to efficient reimbursement rate and practice pattern in this country. Asia-Pacific was also observed to be the most growing market. North America was observed to be the second largest IVUS market globally as according to Centre for Disease Control and Prevention (CDC), about 5.1 million people in the United States have heart failure and it costs the nation an estimated USD 32 billion each year. High intake of fats through food and lack of physical activities has increased the obese population in North America. Comparatively, reimbursements offered for IVUS in the U.S. are lower and vary significantly among regions of the country. IVUS usage in Europe is also struggling due to the lack of reimbursements in many countries across the region. Rest of the World (RoW) was also observed to be the growing geographic region after Asia-Pacific, especially Latin America and gulf countries were observed to be the major markets for IVUS.

Some of the major key players of the market are Volcano Corporation, Boston Scientific Corporation, Terumo Corporation, Siemens Healthcare, Silicon Valley Medical Instruments Inc., Avinger Inc., InfraReDx Inc., eV3 Endovascular, Inc. (Covedien), among others.

Global Surgical Navigation Systems Market to Exhibit 4.50% CAGR 2014-2020 as Preference for Minimally Invasive Surgeries Grows

The intense rivalry between Medtronic Inc., BrainLab AG, and Stryker Corp. points towards a highly competitive landscape of the global market for surgical navigation systems, states a report by Transparency Market Research (TMR). The market is moderately concentrated. The top three participants accounted for a share of nearly 75% in 2013. The manufacturers of surgical navigation systems are increasingly entering into contracts with end users, such as hospitals and medical research institutes, to provide post-purchase services efficiently. This, in turn, is likely to strengthen the relationships between players and end users in the near future, leading to a deepened rivalry between manufacturing companies to capture each greater market share. This competition will intensify further due to the limited growth opportunities in terms of manufacturing cost and product differentiation.

The report offers a comprehensive assessment of the global market for surgical navigation systems. As per the study, the overall market will increase at a CAGR of 4.50% during the period from 2014 to 2020 and reach a value of US$295.5 mn by the end of the forecast period. Compared to other navigation systems, the demand for neurosurgery navigation systems is higher and is likely to remain the same over the coming years.

Demand for Surgical Navigation Systems to Remain Higher in North America

In this study, Asia Pacific, North America, Europe and the Rest of the World have been identified as the key geographical segments of the worldwide surgical navigation systems market. With a share of 40%, North America acquired the leading position in the overall market in 2013. The presence of an advanced healthcare infrastructure, together with a well-structured regulatory framework, has been driving the adoption rate of surgical navigation systems in this region. The trend is likely to continue over the forecast period, ensuring the dominance of North America.

Asia Pacific is also expected to record a robust rise in the uptake of surgical navigation systems in the coming years due to the increasing medical expenditure in this region. Analysts project the demand for these systems to expand at a CAGR of 7.60% between 2014 and 2020 in Asia Pacific, reports the research study.

Increased Awareness Regarding Usage and Benefits of Surgical Navigation Systems to Boost Adoption

“The increased awareness regarding the benefits that surgical navigation systems offer has played a significant role in driving their demand,” says an analyst at TMR. The leading manufacturers are taking initiatives to create more awareness about the applications and the benefits of these systems among healthcare professionals, which, in turn, is accelerating their sales substantially.

Apart from this, the rising trend of minimally invasive surgeries has also impacted positively on the adoption of surgical navigation systems, globally. As these systems impart accuracy to minimally invasive surgical procedures, the risk of failure reduces significantly as compared to conventional procedures, notes the study.

View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2646

High Initial and Maintenance Cost to Hamper Market’s Growth

In the coming years, though the demand for surgical navigation systems will escalate considerably, the cost associated with these systems may restrict the market from rising steadily. The average price of a surgical navigation system ranges from US$0.2 mn to US$0.65 mn on the basis of the combination of software employed on its basic unit.

Taking the initial investment and the maintenance cost in consideration, it will become difficult for a lot of healthcare organizations and research institutes to afford these systems. This factor may lead to a decline in their usage over the next few years.

The study presented here is based on a report by Transparency Market Research (TMR) titled “Surgical Navigation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”

Global Optical Imaging Market to Exhibit 4.50% CAGR from 2014 to 2020; Highest use Seen in Oncology Applications

Featuring the presence of only a few global and domestic players, the global optical imaging market exhibits a consolidated vendor landscape. With key players looking to gain competitive advantage, the introduction of novel technologies or products could induce competition among the top players in the market, states Transparency Market Research (TMR) in a new study. TMR expects the overall rivalry in the global optical imaging market to remain moderate to high between 2014 and 2020. Some of the leading players operating in the market are St. Jude Medical, Inc., Carl Zeiss AG, Michelson Diagnostics Ltd., Topcon Medical Systems, Inc., Bioptigen, Inc., and Heidelberg Engineering GmbH.

The global optical imaging market is forecast to exhibit an impressive CAGR of 10.8% between 2014 and 2020. The market stood at US$1.06 bn in 2013 and is expected to reach US$2.19 bn by the end of 2020. By application, the oncology segment is expected to rise at a considerably high CAGR of 15.1% CAGR during the forecast period. Regionally, the market was dominated by North America with a share of 46.1% in 2013.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2093

Demand for Optical Imaging to Rise in Response to Increasing Incidence of Lifestyle Diseases

The market is projected to witness considerable growth in the forthcoming years as the prevalence of disorders related to skin, teeth, eye, and other organs increase. As people grow more accustomed to sedentary lifestyle, extended working hours, and lack of exercise, they facing more number of health problems than ever before. Lifestyle diseases such as hypertension and diabetes have thus become highly prevalent worldwide. This diseases often make people vulnerable to problems related to eyes, skin, teeth, and other vital organs, thus in turn fuelling demand for optical imaging devices.

Rising Geriatric Population to Fuel Demand for Optical Imaging Devices

“Currently, optical imaging devices such as HIS, OCT, NIRS, and PAT find application across treatment modalities for dentistry, ophthalmology, cardiology, and dermatology,” said a lead TMR analyst. The rising aging population will also create opportunities for the optical imaging market as the risk of chronic ailments increases with the increasing age. “Since geriatric population are more prone to dental and visual problems, and cardiovascular diseases, they make a key consumer segment in the global optical imaging market,” observes the TMR report’s author.

Besides this, the market is also expected to gain impetus from the increasing adoption of optical imaging technologies across diverse applications.

Absence of Well-defined Reimbursement Restrains the Market’s Growth

Despite witness positive opportunities worldwide, the lack of proper reimbursement facilities is inhibiting the growth of optical imaging modalities, particularly in developing countries. A majority of the optical imaging technologies available in the market are novel techniques and are thus not included within the reimbursement policies prevalent in developing nations. Due to this, in emerging economies such as India, Mexico, China, and Brazil, which are highly price-sensitive, only a limited penetration of optical imaging modalities is noted. The lack of well-defined reimbursement policies are proving restraint for the market’s penetration across these countries.

Besides this, the lack of clinical data validation is also creating bottlenecks for the market. For instance, there is inadequate data authenticating the use of the Fourier-domain OCT to identify disease progression in glaucoma patients. This may restrain the adoption of OCT across the world.

Application across Diverse Segment to Boost Market’s Growth in Forthcoming Years

Optical imaging is gradually finding applications across oncology, ophthalmology, internal medicine, gastroenterology, gynecology, cardiology, in vivo imaging, dentistry and urology. The technology enables superior tissue penetration with high image resolution. These intrinsic benefits of optical imaging will help key players mitigate the aforementioned concerns in the forthcoming years.

Furthermore, the market is also expected to gain impetus from the presence of the large unmet needs of population residing in emerging economies.

This review is based on the findings published by TMR in a report, titled “Optical Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”

Iraq Healthcare (Surgical Procedures) Market to See Highest Demand for Cardiovascular Surgeries, to Reach US$530.3 mn by 2022

The two leading players operating in the Iraq healthcare market are Siemens Healthcare and Koninklijke Philips N.V. The collective share of these companies as of 2013 stood at 31.7%. Companies are focusing on collaborative agreements with the government to secure and strengthen their position in the overall market, observes Transparency Market Research in its latest publication. "These players are also aiming at providing rehabilitation programs through their services to help the displaced patients regain a normal life after the treatment," states the lead author of this research report. Thus, diversifying product portfolios and customizing offerings to meet the needs of the patients will be the key business strategies defining the success of these companies.

The research report states that the Iraq healthcare market is expected to represent an opportunity worth US$530.3 mn by the end of 2022 as the market exhibits a CAGR of 7.8% between 2014 and 2022. This market is expected to be driven by the increasing demand for cardiac procedures, as the country is witnessing a surge in the number of patients suffering from cardiovascular disease. Thus, the cardiac procedures segment is expected to rise at a CAGR of 8.3% during the forecast period. The orthopedic procedures segment is also anticipated to be an emerging one as the worn-torn nation limps back to normalcy nursing the wounds of several civilians and soldiers over the course of next few years. The orthopedic procedures segment in the overall market is expected to expand at a CAGR of 7.0% between 2014 and 2022.

War Impels Government to Spend on Healthcare Infrastructure

The long-drawn war in Iraq has impelled the government to spend on building a healthcare infrastructure. To repair the damages to the primary care sector the Government of Iraq allocated US$12 bn for health care expansion in 2014. Such projects will see three specialized cardiac centers, eight public hospitals, multiple primary care centers for children and women, and a hospital for treating cancer and a neurology center as well. Over the forecast period, the country will also have several psychiatric rehabilitation hospitals to treat the patients suffering from traumas of war. Iraq is poised to be a lucrative healthcare market as the Government and international organizations such as WHO are anticipated to invest heavy amounts into rebuilding the country's medical setup.

The high prevalence of non-communicable diseases such as cardiovascular diseases, cancer, hypertension, and diabetes have made a significant contribution towards the growth of the Iraq healthcare market. The market is also anticipated to rise as the increasing revenues from the oil industry will fuel the healthcare market of Iraq. These investments will be channelized towards training medical staff, upgrading medical facilities, and funding a healthcare infrastructure for a better tomorrow.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4708

Poor Banking Systems Hamper Healthcare Infrastructure Funding

However, the overall market is being restrained by the slow pace of infrastructural growth as the poor banking system is unable to fund the projects. The financial instability and the restrictive macroeconomic policies governing the country are likely to hamper the growth of the market as well. Currently, the banking system is still trying to recover from bad debts and losses due to the political tensions and war in the country. Furthermore, as the majority of the population in Iraq does not have a bank account, it is becoming increasingly difficult for banks to recover from the losses and fund infrastructural projects. The growth of this market is also being shadowed by the political unrests that are preventing foreign companies from investing in the Iraq healthcare market. The high levels of corruption, crime, and violence is creating a deterrant to the overall market.

The aforementioned review has been based on Transparency Market Research’s report, titled “Iraq Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022.”

Urolithiasis Management Devices Market expected to rise to US$1.78 bn up to 2024

Despite the presence of a large number of regional players, the global market for urolithiasis management devices is dominated by few large vendors having substantial budgets for research and development of new technologies and innovative products, observes TMR in a recent report. Companies such as Boston Scientific Corporation, C. R. Bard, Inc., and Cook Group command prominent positions in the global market owing to their strong geographic presence, excellent distribution networks, and the financial power to acquire niche device developers across the globe. The degree of competition is high in the maturing market, with frequent changes to the development dynamics owing to rapid advancements in supporting technologies.

Transparency Market Research estimates that the global urolithiasis management devices market will expand at a healthy 4.5% CAGR over the period between 2016 and 2024. The market’s worth is estimated to be US$1.26 bn in 2016 and is expected to rise to US$1.78 bn by 2024.

Asia Pacific to Emerge as Most Promising Regional Market

Of the key urolithiasis management device types available in the global market, the segment of shockwave lithotripters is presently the dominant revenue generator, with a valuation of US$789.2 mn in 2015, and is expected to account for a share of 65% in the global market by 2016. Of the key end users of urolithiasis management devices, the segment of clinics led the global market, holding a share of 55% of the market’s overall revenues in 2015. Geography-wise, North America led with 36% share in the global market in the same year. Over the period between 2016 and 2024, however, Asia Pacific is projected to emerge as the most promising regional market for urolithiasis management devices owing to the large geriatric population and a rising base of high-income patients.

Technological Advancements to Stimulate Market Growth

The market for urolithiasis management devices is primarily driven owing to the rising prevalence of kidney stones among the global population. Factors such as obesity, changing lifestyles, and ageing are the chief causes triggering the formation of kidney stones among humans. Studies state that at least 30% of the world’s population is presently obese or overweight. Geriatrics (people with more than 60 years of age) account for more than 900 mn people of the world’s population presently. The United Nations’ Department of Economic and Social Affairs states that this number will increase by 56% between 2015 and 2030 and rise to 1.4 bn by 2030.

Along with these factors, the introduction of a variety of non-invasive treatment methods in the global urolithiasis management devices market has also encouraged the excellent growth of the market in the past few years. The significant reduction in treatment duration and effective results are compelling an increased number of patients to demand newer and technologically advanced treatment methods for kidney stones.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2252

High Risk of Damage to Urinary Tract Leads to Apprehension about Urolithiasis Management Devices

Certain urolithiasis procedures such as the lithotripsy involve shockwaves that are sent across the body to trigger kidney stones with high precision force. Such treatments may result in damage to soft tissues and could also potentially lead to a permanent loss of renal functions. This factor leads to increased concerns among patient about the potential side-effects of novel technologies and hampers the overall adoption of urolithiasis management devices to a notable extent. Another key challenge for the global urolithiasis management devices is the high cost of certain latest and novel technologies, which restrains market’s growth across developing economies to a large extent.

This review of the global urolithiasis management devices market is based on a recent market research report published by Transparency Market Research, titled “Urolithiasis Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Telemedicine Market Outlook and Forecast up to 2020

It is often said that no matter what happens to the global financial scenario, the healthcare industry shall see a constant growth so long as the population grows; this is because healthcare belongs to the necessity category for humans besides essential food grains. Traditional medical practices have been followed since the time of Hippocrates, which generally involved patients traveling to the locale of the physician and waiting for a long period of time to get an appointment with the doctor. This proved to be a hindrance that humans conveniently evolved, so as to preserve order in the system of medicine. Serious cases were tended to on a priority basis and were followed by the elite customers who had the capital to leisurely finance their medical expenses promptly. This system affected the common man who had any minor, non-life threatening malaise that wasn’t a priority. Geriatric patients too were neglected merely on the fact that they had already passed their lifetime. Modern day medicine however did not see any discrimination, but the central factor of travelling to a physician and waiting for an appointment still persisted. Telecommunication technology paved way for a revolutionary change in the medical sector with mobile, smartphones, computers, radio, and the internet. Telemedicine became an amalgamation of medical sciences and telecommunication technology, thereby extending the reach of medical assistance to areas and locations that were previously difficult to access instantaneously. It also provided the convenience of home or clinic to patients and medical practitioners respectively. Telemedicine greatly increased the scope of healthcare industry by providing emergency care and saving lives globally. It is therefore agreed in a consensus among medical practitioners and patients alike that telemedicine is bound to open huge opportunities in increasing the global quality of healthcare.

The telemedicine market is primarily categorized into medical specialty and service process offered. The specialty segment includes: cardiology, neurology, dermatology, orthopedics, emergency care, internal medicine, gynecology and the other specialty areas that includes: gastroenterology, pediatric care, ophthalmology and dentistry. Dermatology is the clear segment leader in terms of market revenue among the medical specialty segments in telemedicine. This is in correlation with the CDC study that suggested dermatology cases to be among the most reported cases in an ER. The neurology segment is witnessing the fastest growth owing to the rising number of stroke, Alzheimer’s and Parkinson’s cases. Cardiology, orthopedics, emergency care, and internal medicine segments however will undergo reserved growth during the forecast period. The areas such as dentistry, pediatric care and ophthalmology will demonstrate great growth potential and are expected to continue growing in the future with increasing prevalence of related diseases.

Among the various services of telemedicine, tele-consultation leads the present telemedicine market in 2013. On the other hand, tele-monitoring is expected to exhibit the highest growth rate for the forecast period. This was attributed to the growing geriatric and disabled populations who are commonly diagnosed with diabetes and cardiovascular complications. Neurological complications such as stroke, Alzheimer’s and Parkinson’s represent the other reason for the requirement of continuous monitoring of patients. Tele-education, tele-training and tele-surgery are the recent additions to telemedicine that have an attractive growth potential; however they consist of a smaller fraction of the overall global telemedicine market. Tele-care is a well known segment among telemedicine users and providers alike, it mainly comprises chronic and acute care and rehabilitation services offered to home bound patients worldwide.

Geographically, North America was the largest telemedicine market in terms of revenue for the year 2013 followed by the Asia Pacific region. The Asia Pacific region also exhibited the fastest growth rate was and is expected to lead the global market by the end of the decade. Rising populations in rural and urban areas and increased government initiatives are the primary reasons why this region boasts of a high growth rate. This coupled with the existence of a large number of technology manufacturing units in this region offering cheaper equipment, shall ensure steady market penetration and market growth for the future.

Request free Sample pages of premium Research Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032

The telemedicine market is observed to be a highly diverse market with the presence of a large number of big and small players. However a noted few players present themselves as the largest telemedicine companies globally. These include, CISCO Systems, Inc., AMD Global Telemedicine, Inc., Polycom Corp. and McKesson Corporation, to name a few. Among these, CISCO Systems, Inc was found to have the largest global presence, offering a wide range of telemedicine services worldwide. Their market presence in emerging markets and expertise in providing software solutions paved the way to their stronghold in the industry. The other companies include, Agfa HealthCare NV, Allscripts Healthcare Solutions, Inc., AMD Global Telemedicine, Inc., CARDIOCOM, LLC, CISCO Systems, Inc., F. Hoffmann-La Roche Ltd., Honeywell HomMed LLC, InTouch Technologies, Inc., LifeWatch AG, Medtronic, Inc., OBS Medical Ltd., Siemens Healthcare, and McKesson Corp.

Reprocessed Medical Devices Market - Worldwide Market Shares, Strategies, and Forecasts 2014 to 2020

The global market for reprocessed medical devices features a markedly high level of consolidation, with Stryker Sustainability Solutions, Inc. alone holding a share of nearly 62% of the overall market in 2013, reports TMR in a recent market research report. Well-managed supply channels and a strong distribution network have allowed the company to take a coveted spot in the global reprocessed medical devices market.

Owing to the prominence of a few vendors in the market, entry barriers for new vendors are high. Along with the dominance of a very small number of companies, factors such as the requirement of a steady supply of used medical devices, regulatory control exercised by several supervisory bodies, and the necessity of strong distribution networks are challenging new vendors in the global reprocessed medical devices market. However, developing economies, with vast growth opportunities and a highly unorganized reprocessing industry could allow easy admittance to new vendors. Some more of the market’s notable participants are Hygia Health Services, Inc., Centurion Medical Products Corporation, Medline ReNewal, SterilMed, Inc., and SureTek Medical.

The global reprocessed medical devices market is expected to exhibit an exceptional 19.3% CAGR by revenue over the period between 2014 and 2020. The market had a revenue-wise valuation of US$898.7 mn in 2015. In terms of volume, the global market is expected to rise to 56.04 mn by 2020.

Rising Pressure on Reducing Medical Waste and Demand for Reducing Medical Costs Drive Market

That using reprocessed medical devices could help healthcare facilities in saving big bucks is not a difficult guess. The Association of Medical Device Reprocessors (AMDR) states that any typical hospital could save anywhere between US$500,000 to US$2 mn a year using reprocessed medical devices. What’s more, orthopedic surgery centers could save up to US$20,000 per operating room a year by employing reprocessed medical devices. Such vast savings are the chief factor that reprocessed medical devices appeal to healthcare industries across the globe, no matter how strong or weak the economy of a country.

In developed economies, the rising demand to bring down healthcare expenses along with the several regulations requiring proper disposal or reuse of medical devices with a view of reducing the volumes of medical waste are working in favor of the medical devices reprocessing industry. In developing and under-developed economies, on the other hand, the potential of reprocessed medical devices in bridging the gap between the vast demands for healthcare facilities and their absence, especially in remote areas, could allow the global reprocessed medical devices market achieve traction.

Reluctance in Adopting Used Products in Developed Economies and Preference for In-house Reprocessing in Emerging Ones Hinder Market’s Growth

In certain developed countries such as the U.K. and France, healthcare providers and surgical centers are highly reluctant regarding the use of reprocessed medical devices. The lack of awareness and negative perception about the safety, product quality, and efficacy of reprocessed medical devices are key to the low adoption of reprocessed medical devices in such regions.

Download Free exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2064

In developing countries, such as India, China, Singapore, and many other countries in the Middle East, Africa, and Asia Pacific, the large-scale adoption of professionally reprocessed medical devices is hindered due to the high preference for in-house reprocessing.

The lack of specific regulatory guidelines governing the process of medical device reprocessing has helped flourish the intake of easily and economically reprocessed medical devices recovered through in-house processing. This factor is expected to emerge as a key challenge to the overall development of the global reprocessed medical devices market in emerging economies in the next few years.

Cardiovascular Devices Take the Lead

The segment of cardiovascular devices saw the most traction, with 13.69 mn devices reprocessed and/or sold globally in 2015. In terms of revenue as well, the segment of reprocessed cardiovascular devices held the dominant position, with a valuation of US$599.3 mn in the same year. Geography-wise, North America emerged as the clear leader in the global reprocessed medical devices market as of 2015.

This review is based on a recent report published by Transparency Market Research, titled “Reprocessed Medical Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”